Semaglutide study suggests such drugs could have wider benefits, though researchers find shrinking waistlines linked to better heart outcomesThe weight-loss drug semaglutide cuts the risk of heart attack or stroke regardless of how many kilograms people lose, the largest study of its kind has found.However, shrinking waist size – a sign of less belly fat – was linked to better heart outcomes, according to the research. Continue reading...